Neurogene

Neurogene is a clinical-stage biotechnology company specializing in the development of genetic medicines for rare and devastating neurological diseases. Its business model centers on advancing gene therapy candidates, such as NGN-401 for Rett syndrome and NGN-101 for CLN5 Batten disease, through clinical trials and strategic partnerships. Neurogene is positioned as an innovator in the genetic medicine market, with a focus on high unmet medical needs.

Company Facts

• Headquarters: New York, United States
• Founded: 2018
• Employees: 107
• Type: Public Corporation
• Website: https://www.neurogene.com
• Industries: Biotechnology, Healthcare, Genetic Medicine